LEADER 01001nam0-2200313 --450 
001 9910284643403321
005 20180928142745.0
010   $a1588900312$bNew^York
010   $a3135584046$bStuttgart
100   $a20180928d2001----kmuy0itay5050    ba
101   $aeng
102   $aDE
105   $a        001yy
200 1 $aPharmaceutical substances$esyntheses, patents, applications$fAxel Kleemann and Jurgen Engel$gBernhard Kutscher and Dietmar Reichert
205   $a4. ed.
210   $aStuttgart$aNew York$cThieme$d2001
215   $a2 volumi (XXXIII, XXXIII, 2488 p.)$cill.$d25 cm
700  1$aKleemann,$bAxel$090203
701  1$aEngel,$bJurgen$090204
702  1$aKutscher,$bBernhard
702  1$aReichert,$bDietmar
801   $aIT$bUNINA$gREICAT$2UNIMARC
901   $aBK
912   $a9910284643403321
952   $a80 XIII 160.1$bBFA76/2018$fFFABC
952   $a80 XIII 160.2$bBFA77/2018$fFFABC
959   $aFFABC
996   $aPharmaceutical substances$9977565
997   $aUNINA